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Background
Breast cancer is the most common type of cancer in
women. Up to 30% of all breast cancers are reported to
occur in the over 70 year age group and these percen-
tages may increase in the near future as the mean age of
the general population grows up.
The standard treatment for early breast cancer in
women of all ages was surgery until the late 1970s,
when primary endocrine therapy was first described as
an alternative to standard therapy for older women
(Bradbeer 1983). Primary endocrine therapy means the
use of Tamoxifen, without surgery, radiotherapy or
chemotherapy.
The incidence of significant co-morbidity is greater in
the elderly, making general anaesthesia more hazardous.
Material and methods
From January 2008 to July 2009 we treated 68 women
older than 70 years (mean age 73 years). 59 of them
were surgically treated (mastectomy and axillary lym-
phoadenectomy or conserving surgery and axillary
sentinel node biopsy with or without adjuvant endocrine
therapy) and 9 of them were treated with primary endo-
crine therapy (7 of them were older than 80 years and
two between 70 and 79). 5 of them had been considered
unfit for surgery because of their poor general condition
and 4 refused surgery. For all them we assessed the oes-
trogen receptor status, performing a core-biopsy. All
women were affected by ER-positive tumours.
Results and discussion
At a mean follow up of 9 months only one patient of 68
died for causes not related to breast cancer.
Nowadays very few people result unfit for surgery
because breast conserving surgery has made morbidity
and mortality rates very low. However we can consider
primary endocrine therapy for women with ER-positive
tumours with serious co-morbidity or who refuse
surgery.
We can assert that in a group of women with reduced
life expectancy and ER-positive tumours, primary endo-
crine therapy may be an appropriate treatment choice.
Moreover more trials are needed to evaluate the clinical
effectiveness of aromatase inhibitors as primary therapy
for old women with ER-positive tumours.
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